Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Oct 1:188:740-750.
doi: 10.1016/j.ijbiomac.2021.08.076. Epub 2021 Aug 14.

SARS-CoV-2 (Covid-19) vaccines structure, mechanisms and effectiveness: A review

Hadis Fathizadeh  1 , Saman Afshar  2 , Mahmood Reza Masoudi  3 , Pourya Gholizadeh  4 , Mohammad Asgharzadeh  5 , Khudaverdi Ganbarov  6 , Şükran Köse  7 , Mehdi Yousefi  8 , Hossein Samadi Kafil  9
Affiliations
Review

SARS-CoV-2 (Covid-19) vaccines structure, mechanisms and effectiveness: A review

Hadis Fathizadeh et al. Int J Biol Macromol. .

Abstract

The world has been suffering from COVID-19 disease for more than a year, and it still has a high mortality rate. In addition to the need to minimize transmission of the virus through non-pharmacological measures such as the use of masks and social distance, many efforts are being made to develop a variety of vaccines to prevent the disease worldwide. So far, several vaccines have reached the final stages of safety and efficacy in various phases of clinical trials, and some, such as Moderna/NIAID and BioNTech/Pfizer, have reported very high safety and protection. The important point is that comparing different vaccines is not easy because there is no set standard for measuring neutralization. In this study, we have reviewed the common platforms of COVID-19 vaccines and tried to present the latest reports on the effectiveness of these vaccines.

Keywords: Adenovirus; Covid-19; Effectiveness; Inactivated; Infection; Sars-Cov-2; Vaccine.

PubMed Disclaimer

Conflict of interest statement

None to declare.

Figures

Fig. 1
Fig. 1
Classification of common vaccines based on the translation process requirement for immunization.
Fig. 2
Fig. 2
Different types of SARS-CoV-2 vaccine candidates and immune response to vaccines.
See this image and copyright information in PMC

References

    1. Ozma M.A., Maroufi P., Khodadadi E., Köse S., Esposito I., Ganbarov K., Dao S., Esposito S., Dal T., Zeinalzadeh E. Clinical manifestation, diagnosis, prevention and control of SARS-CoV-2 (COVID-19) during the outbreak period. Infez. Med. 2020;28(2):153–165. - PubMed
    1. Khodadadi E., Maroufi P., Khodadadi E., Esposito I., Ganbarov K., Espsoito S., Yousefi M., Zeinalzadeh E., Kafil H.S. Study of combining virtual screening and antiviral treatments of the Sars-CoV-2 (Covid-19) Microb. Pathog. 2020;145 - PMC - PubMed
    1. Najafi K., Maroufi P., Khodadadi E., Zeinalzadeh E., Ganbarov K., Asgharzadeh M., Kafil H.S. SARS-CoV-2 receptor ACE2 and molecular pathway to enter target cells during infection, reviews in medical. Microbiology. 2020
    1. Abd El-Aziz T.M., Stockand J.D. Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2)-an update on the status. Infect. Genet. Evol. 2020;83 - PMC - PubMed
    1. Fathizadeh H., Taghizadeh S., Safari R., Khiabani S.S., Babak B., Hamzavi F., Ganbarov K., Esposito S., Zeinalzadeh E., Dao S., Köse S., Kafil H.S. Study presence of COVID-19 (SARS-CoV-2) in the sweat of patients infected with Covid-19. Microb. Pathog. 2020;149:104556. - PMC - PubMed